Pfizer Acquires a Stem-Cell Therapy
Monday, December 21, 2009 - 00:49
in Health & Medicine
Pfizer will have the rights to develop Athersys’s cells to treat inflammatory bowel disease, which is in early human testing.
Pfizer will have the rights to develop Athersys’s cells to treat inflammatory bowel disease, which is in early human testing.